Medicine and Dentistry
Systematic Review
95%
Meta-Analysis
95%
Atrial Fibrillation
82%
Congestive Heart Failure
63%
Brugada Syndrome
50%
Risk Stratification
48%
Cohort Analysis
37%
Maturity Onset Diabetes of the Young
35%
Diabetes Mellitus
31%
Sudden Cardiac Death
30%
Cardiovascular System
29%
Cardiovascular Disease
28%
All Cause Mortality
26%
Hazard Ratio
25%
Malignant Neoplasm
24%
Apoplexy
23%
Heart Ventricle Arrhythmia
23%
Diseases
23%
Electrocardiogram
23%
Odds Ratio
22%
Repolarization
21%
Sodium Glucose Cotransporter 2 Inhibitor
21%
COVID-19
19%
Ventricular Tachycardia
19%
Observational Study
18%
Heart Left Ventricle Ejection Fraction
16%
Proportional Hazards Model
16%
New-Onset Atrial Fibrillation
15%
Patient with Type 2 Diabetes
15%
Faintness
15%
Cardiac Dysrhythmia
15%
Dipeptidyl Peptidase-4 Inhibitor
14%
Ventricular Fibrillation
14%
P Wave
14%
Ablation
14%
T-Peak to T-End
14%
Glycon
13%
Adverse Outcome
13%
Hemoglobin A1c
12%
Brain Ischemia
12%
Ejection Fraction
12%
Prostate Cancer
12%
Myocardial Infarction
12%
Comorbidity
12%
Heart Atrium Remodeling
11%
Recurrent Disease
11%
Percutaneous Coronary Intervention
11%
Prospective Cohort Study
11%
Biological Marker
11%
Diabetes
11%
Pharmacology, Toxicology and Pharmaceutical Science
Atrial Fibrillation
100%
Congestive Heart Failure
69%
Cohort Study
57%
Diabetes Mellitus
50%
All Cause Mortality
44%
Heart Arrhythmia
38%
Disease
37%
Non Insulin Dependent Diabetes Mellitus
36%
Cardiovascular Disease
30%
Randomized Controlled Trial
29%
Sodium Glucose Cotransporter 2 Inhibitor
29%
Malignant Neoplasm
28%
Heart Ventricle Arrhythmia
28%
Sudden Cardiac Death
27%
Cerebrovascular Accident
24%
Heart Atrium Remodeling
22%
Coronavirinae
19%
Prostate Cancer
18%
Dipeptidyl Peptidase IV Inhibitor
18%
Heart Infarction
18%
Observational Study
17%
Arrhythmogenesis
17%
Recurrent Disease
16%
Heart Ventricle Tachycardia
15%
Immune Checkpoint Inhibitor
15%
Metformin
15%
Leporidae
14%
Atherosclerosis
14%
New-Onset Atrial Fibrillation
14%
Biological Marker
14%
Brugada Syndrome
13%
Hemoglobin A1c
13%
Heptanol
12%
Comorbidity
12%
Androgen
11%
Heart Failure with Preserved Ejection Fraction
11%
Cardiovascular Risk
11%
Brain Ischemia
10%
Long QT Syndrome
10%
Fibrosis
10%
Combination Therapy
10%
Antiarrhythmic Agent
10%
Heart Ventricle Remodeling
10%
Heart Injury
10%
Adverse Outcome
10%
Cardiovascular Mortality
9%
Myocardial Disease
9%
Myocarditis
9%
Ion Channel
9%
Randomized Clinical Trial
9%
Biochemistry, Genetics and Molecular Biology
Atrial Fibrillation
73%
Brugada Syndrome
36%
Cohort Study
32%
All Cause Mortality
26%
Cardiac Dysrhythmia
25%
Repolarization
20%
Ventricular Tachycardia
16%
Oxidative Stress
15%
Heptanol
15%
Electrocardiogram
14%
Action Potential
13%
Observational Study
12%
Medline
12%
Sudden Cardiac Death
11%
Heart Ejection Fraction
10%
Endoplasmic Reticulum Stress
10%
Ventricular Fibrillation
10%
Ion Channel
9%
Cardiac Muscle Cell
9%
Cardiovascular Mortality
9%
Mitochondrial Disorder
9%
Signal Transduction
8%
P Wave
8%
Cochrane Library
7%
Leporidae
7%
C-Reactive Protein
7%
Long QT Syndrome
7%
APD90
7%
Dispersion
7%
Cardiac Resynchronization Therapy
7%
Blood Pressure Variability
7%
Immune Checkpoints
7%
Long Non-Coding RNA
7%
Action Potential Duration
6%
Hypokalemia
6%
Sodium Channel
6%
Randomized Controlled Trial
6%
Systolic Blood Pressure
5%
Mendelian Randomization
5%
Sodium-Glucose Cotransporter 2 Inhibitors
5%
Effective Refractory Period
5%
Body Mass
5%
ST Elevation
5%
Prospective Cohort Study
5%
N-Terminus
5%
Embase
5%